Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 32% ± 9% | |
lung | 13 studies | 32% ± 13% | |
intestine | 9 studies | 25% ± 12% | |
brain | 9 studies | 27% ± 7% | |
kidney | 7 studies | 26% ± 8% | |
eye | 7 studies | 33% ± 15% | |
bone marrow | 5 studies | 25% ± 6% | |
lymph node | 5 studies | 26% ± 3% | |
pancreas | 4 studies | 39% ± 14% | |
uterus | 4 studies | 37% ± 13% | |
breast | 4 studies | 24% ± 5% | |
liver | 4 studies | 36% ± 21% | |
placenta | 3 studies | 36% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 4587.71 | 1445 / 1445 | 100% | 69.32 | 183 / 183 |
intestine | 100% | 4912.02 | 966 / 966 | 100% | 88.45 | 527 / 527 |
lung | 100% | 4487.24 | 578 / 578 | 100% | 101.21 | 1155 / 1155 |
ovary | 100% | 4894.17 | 180 / 180 | 100% | 97.50 | 430 / 430 |
prostate | 100% | 4354.25 | 245 / 245 | 100% | 101.08 | 502 / 502 |
stomach | 100% | 3336.00 | 359 / 359 | 100% | 80.06 | 286 / 286 |
uterus | 100% | 5692.61 | 170 / 170 | 100% | 141.10 | 459 / 459 |
brain | 100% | 4937.69 | 2641 / 2642 | 100% | 136.31 | 705 / 705 |
breast | 100% | 5254.31 | 459 / 459 | 100% | 109.48 | 1117 / 1118 |
kidney | 100% | 4164.06 | 89 / 89 | 100% | 90.97 | 900 / 901 |
thymus | 100% | 4776.27 | 653 / 653 | 100% | 139.73 | 604 / 605 |
bladder | 100% | 4957.95 | 21 / 21 | 100% | 106.33 | 503 / 504 |
skin | 100% | 4735.96 | 1809 / 1809 | 100% | 134.57 | 471 / 472 |
liver | 100% | 2156.51 | 225 / 226 | 100% | 63.36 | 406 / 406 |
adrenal gland | 100% | 4395.16 | 258 / 258 | 99% | 72.48 | 227 / 230 |
pancreas | 98% | 1581.16 | 321 / 328 | 99% | 86.29 | 177 / 178 |
adipose | 100% | 5207.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 5645.72 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 171.71 | 29 / 29 |
spleen | 100% | 4696.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 120.05 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 87.79 | 1 / 1 |
muscle | 100% | 2941.55 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 3101.06 | 848 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 70.37 | 78 / 80 |
peripheral blood | 93% | 3237.44 | 861 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0045171 | Cellular component | intercellular bridge |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
GO_0030544 | Molecular function | Hsp70 protein binding |
Gene name | DNAJC8 |
Protein name | DnaJ homolog subfamily C member 8 (Splicing protein spf31) DnaJ heat shock protein family (Hsp40) member C8 |
Synonyms | SPF31 HSPC331 HSPC315 |
Description | FUNCTION: Suppresses polyglutamine (polyQ) aggregation of ATXN3 in neuronal cells . . |
Accessions | S4R3J5 ENST00000263697.6 O75937 ENST00000603289.5 |